ANIP (ANI Pharmaceuticals) Earnings per share growth rate in current year
How can generic drug production be scaled without a proportional increase in costs? By tracking the percentage of EPS deviation from last year's levels on GURU.Markets, we note a trend where 19.70 shows the current volume of this metric. The solution lies in the management's operational efficiency during M&A integration and strict compliance with environmental chemical disposal regulations, which stabilizes the development of ANI Pharmaceuticals (ANIP).
Financial and market metric breakdowns for ANI Pharmaceuticals Inc (ANIP)
- stock price and consensus target price:
- business market valuation indicators:
- balance sheet equity data:
- debt and liquidity details:
Debt to Equity Ratio ANI Pharmaceuticals|ANIP - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient ANI Pharma|ANIP - Company Total Debt|Debt to Net Assets Ratio ANI Pharmaceuticals, Inc.|ANIP - Company Long-Term Debt|Current Liabilities ANI Pharmaceuticals|Intermediate Coverage Ratio anipharmaceuticals.com
- net income and valuation multiples indicators:
ANIP - Net Profit|Projected Future Earnings ANI Pharmaceuticals|ANIP - Price to Earnings Ratio|Future Price to Earnings Multiple anipharmaceuticals.com|ANIP - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio ANI Pharmaceuticals|ANIP - Operating profit EBITDA|Net earnings per share (EPS TTM) ANI Pharmaceuticals|ANIP - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months anipharmaceuticals.com|ANIP - Earnings growth in current year|Expected net earnings per share growth next year ANI Pharmaceuticals
- sales volume and revenue information:
Summary company analysis:ANI Pharmaceuticals Corp (ANIP)
In-house manufacturing capabilities in the US and a specialization in shortage drugs provide ANI Pharmaceuticals (ANIP) with high margins, directly impacting the efficiency of its profit generation. This indicator measures the rate of change in net income per share relative to the previous year, allowing investors to assess real business growth, which is clearly reflected in the current year-over-year EPS price action.
Main competitors
Earnings per share growth rate in current year Haleon Corp (HLN)|KVUE (Kenvue Inc) - Earnings growth in current year|Earnings per share growth rate in current year veronapharma.com VRNA|Earnings per share growth in current year Jyong Biotech (MENS)|LGND (Ligand Pharmaceuticals Incorporated) - Earnings per share increase in current year|Earnings growth in current year AMRX (Amneal Pharmaceuticals, Inc.)|PRGO (Perrigo Company) - Earnings per share trend in current year|ALVO - Earnings per share growth in current year|Expected net earnings per share growth this year liquidia.com LQDA|Galapagos (GLPG) - Earnings per share growth in current year|Earnings per share growth this year MNKD|AMPH (Amphastar) - Earnings growth in current year|Pacira Corp (PCRX) - Expected net earnings per share growth this year|Earnings per share growth in current year ARS Pharma (SPRY)|Earnings growth in current year Theravance Biopharma, Inc. (TBPH)|Aquestive Therapeutics - Net earnings per share growth this year|Earnings per share increase in current year SCPH|Tectonic Therapeutic Inc. - Earnings growth in current year|Earnings per share trend in current year TNXP|SXTC (China SXT Pharmaceuticals) - Net earnings per share growth this year|Eupraxia Pharmaceuticals (EPRX) - Earnings growth in current year|Earnings per share growth in current year BioHarvest Sciences, Inc.|EXOZ: Earnings per share increase in current year|Earnings growth in current year ORMP|ENTX - Earnings per share growth rate in current year|Earnings per share growth in current year MindWalk Holdings, Inc. HYFT|Earnings growth in current year abvcpharma.com ABVC|CPIX - Earnings per share growth in current year|Earnings per share trend in current year QNTM|FGEN (FibroGen Corporation) - Net earnings per share growth this year|Net earnings per share growth this year Telomir Pharma|Net earnings per share growth this year RANI|Earnings per share growth rate in current year synergychc.com SNYR|Earnings per share growth in current year Rallybio Corp (RLYB)|LEXX - Earnings per share growth rate in current year|Pulmatrix Inc - Net earnings per share growth this year|Earnings per share increase in current year PTHL|Aptorum Group Ltd - Earnings growth in current year|Expected net earnings per share growth this year Lyra Therapeutics LYRA|IBO: Earnings growth in current year|TNFA (TNF Pharma) - Earnings per share growth in current year|Earnings per share growth in current year cbdmd.com|Earnings per share growth this year PRFX (PainReform Corp)|Earnings growth in current year CYTO|Net earnings per share growth this year Lipella Pharmaceuticals LIPO|Earnings per share growth in current year OptiNose OPTN|Pieris Pharmaceuticals Inc - Earnings per share growth in current year|Procaps Group Corp - Earnings growth in current year|Expected net earnings per share growth this year Petros Pharma PTPI|Qilian International Holding Group Limited (QLI) - Earnings per share growth in current year|ACELYRIN (SLRN) - Earnings growth in current year|Earnings per share growth in current year TFF Pharmaceuticals
